Prdm4 was initially cloned as a candidate tumor suppressor gene in human cancers (75) and characterized as a cytoplasmic effector molecule acting downstream of the p75 neurotrophin receptor in response to nerve growth factor signaling (32). Here, PRDM4 is linked to cancer.